A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes

Molecular Therapy

Volumn 4, Issue 3, 2001, Pages 273-279

  Thaler, Sonja ^a   Schnierle, Barbara S ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

CD4 specific; Gene therapy; Retroviral vector; T lymphocytes; Targeting

Indexed keywords

AMINO ACID; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GAG PROTEIN; GLYCOPROTEIN GP 120; MEMBRANE PROTEIN; POL PROTEIN; VIRUS VECTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC CODE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; PACKAGING; PERIPHERAL LYMPHOCYTE; PHYSICAL DISEASE; RETROVIRUS; VIRUS ENVELOPE; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS TYPING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0034842844     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0445     Document Type: Article

References (28)

1. T lymphocyte-directed gene therapy for ADA- SCID: Initial trial results after 4 years
2. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
3. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
4. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells
5. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity
6. Retroviruses
7. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles
8. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1 α promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins
9. High-titer packaging cells producing recombinant retroviruses resistant to human serum
10. Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particles
11. Expression cloning of new receptors used by simian and human immunodeficiency viruses
12. Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro
13. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
14. Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin
15. Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes
16. Concentration of viral vectors by co-precipitation with calcium phosphate
17. Specific incorporation of cyclophilin A into HIV-1 virions
18. Functional association of cyclophilin A with HIV-1 virions
19. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells
20. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans
21. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A
22. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
23. A safe packaging line for gene transfer: Separating viral genes on two different plasmids
24. G protein-coupled receptors in HIV and SIV entry: New perspectives on lentivirus-host interactions and on the utility of animal models
25. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
26. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
27. Improved FACS-Gal: Flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs
28. Current Protocols in Molecular Biology